Despite extensive correlative studies of HIV-infected persons and ex vivo studies of their peripheral blood immune cells, fundamental questions about HIV pathogenesis and immunity remain unanswered. Secondary and mucosa-associated lymphoid tissues are particularly important in HIV infection as primary sites of viral replication and CD4+ T cell depletion, and immune responses, but difficult to study in humans. To study host-pathogen interactions in tissue compartments, and effects of perturbations of immune responses, investigators have turned to animal models. Unfortunately, an ideal animal model of HIV infection has remained elusive. Although simian immunodeficiency virus (SIV) infection of rhesus macaques has provided many critically important insights into retroviral pathogenesis and immunity, there are differences inherent in macaque immune responses to SIV and human responses to HIV. The utility of the traditional mouse model for HIV infection has been limited by HIV's inability to productively infect mouse immune cells. To circumvent this, chimeric "humanized mice" with human immune cells and/or tissues have been generated. Building on earlier models, HU CFAR Core H has been able to make an improved humanized BLT (bone marrow-liver-thymus) mouse model widely available that allows CFAR members to model the development of humoral and cellular human immune responses to HIV, and mucosal transmission of HIV. Working with multiple HU CFAR investigators during the past funding period. Core H has demonstrated that BLT mice recapitulate an "eclipse phase" of HIV infection immediately following exposure of the vaginal mucosa to HIV challenge;generate functional human cellular and humoral immune responses to HIV;and support advanced in vivo imaging of HIV infection by multiphoton-intravital microscopy and bioluminescence imaging. In the coming funding period. Core H will provide access to BLT and other models of humanized mice as a newly named Humanized Mouse Core. Core H will generate these mice and perform experimental procedures including HIV infection with them for all requesting HU CFAR investigators. Additionally, Core H will continue to work on improving the humanized mouse models of HIV that they provide, to expand the areas of investigation that these models can support.
Specific aims of this Core include: 1. Generation of humanized BLT mice. 2. Generation of Hu-HSC mice and Hu-PBL mice. 3. Performance of experimental procedures on humanized mice. 4. Further improvement of humanized mouse models of HIV.

Public Health Relevance

Despite effective treatments, HIV/AIDS remains a leading cause of death and lost years of productive life worldwide. New interventions to prevent or treat HIV are therefore urgently needed, but their development will require better understanding of HIV transmission and pathogenesis, and anti-HIV immune responses. By providing an improved humanized mouse model of HIV infection. Core H will enable HU CFAR members to investigate HIV pathogenesis and transmission, and human anti-HIV immune responses, in vivo.

Agency
National Institute of Health (NIH)
Type
Center Core Grants (P30)
Project #
2P30AI060354-11
Application #
8697497
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Harvard Medical School
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02138
Ballandras-Colas, Allison; Brown, Monica; Cook, Nicola J et al. (2016) Cryo-EM reveals a novel octameric integrase structure for betaretroviral intasome function. Nature 530:358-61
Jain, Sachin; Oldenburg, Catherine E; Mimiaga, Matthew J et al. (2016) High Levels of Concomitant Behavioral Health Disorders Among Patients Presenting for HIV Non-occupational Post-exposure Prophylaxis at a Boston Community Health Center Between 1997 and 2013. AIDS Behav 20:1556-63
Sunshine, Sara; Kirchner, Rory; Amr, Sami S et al. (2016) HIV Integration Site Analysis of Cellular Models of HIV Latency with a Probe-Enriched Next-Generation Sequencing Assay. J Virol 90:4511-9
Krakower, Douglas S; Mayer, Kenneth H (2016) Renal Function and Tenofovir Disoproxil Fumarate for Preexposure Prophylaxis: How Safe Is Safe Enough? J Infect Dis 214:983-5
Mayer, Kenneth H; Krakower, Douglas S; Boswell, Stephen L (2016) Antiretroviral Preexposure Prophylaxis: Opportunities and Challenges for Primary Care Physicians. JAMA 315:867-8
Saito, Akatsuki; Henning, Matthew S; Serrao, Erik et al. (2016) Capsid-CPSF6 Interaction Is Dispensable for HIV-1 Replication in Primary Cells but Is Selected during Virus Passage In Vivo. J Virol 90:6918-35
Krakower, Douglas S; Maloney, Kevin M; Grasso, Chris et al. (2016) Primary care clinicians' experiences prescribing HIV pre-exposure prophylaxis at a specialized community health centre in Boston: lessons from early adopters. J Int AIDS Soc 19:21165
Brown, Carolyn A; Suneja, Gita; Tapela, Neo et al. (2016) Predictors of Timely Access of Oncology Services and Advanced-Stage Cancer in an HIV-Endemic Setting. Oncologist 21:731-8
McDavitt, Bryce; Bogart, Laura M; Mutchler, Matt G et al. (2016) Dissemination as Dialogue: Building Trust and Sharing Research Findings Through Community Engagement. Prev Chronic Dis 13:E38
Gandhi, Rajesh T; Kwon, Douglas S; Macklin, Eric A et al. (2016) Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial. J Acquir Immune Defic Syndr 71:246-53

Showing the most recent 10 out of 844 publications